Clinical Trials Directory

Trials / Completed

CompletedNCT01293968

Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Qazvin University Of Medical Sciences · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

The intention of the study is to study the effects of Ibuprofen, Diphenhydramine and Aluminium MgS in decreasing the signs of recurrent aphthous stomatitis (RAS)

Detailed description

Recurrent aphthous stomatitis (RAS) is the most painful oral lesion with a considerable prevalence . The most common aphthous ulcer treatments include applying topical agents such as antibiotics, Non Steroidal Anti Inflammatory Drugs (NSAIDs) to immunosuppressants. The mixture of Diphenhydramine and Aluminum MgS suspension has been prescribed as an analgesic mouthwash for a long time in order to decrease a great number of oral ulcers symptoms such as aphthous ulcers. Ibuprofen is a potent NSAID with fair anti-inflammatory potential prescribed in dental pains. This double-blind randomized clinical trial was conducted to assess the effect of Ibuprofen, Diphenhydramine and Aluminium MgS mixture on symptoms of aphthous ulcers.40 patients will be participating in this study,20 will receive the mixture of Diphenhydramine and Aluminium MgS while the other group will receive Ibuprofen, Diphenhydramine and Aluminium MgS mixture. All patients will be instructed to apply the drug on the site of the ulcer 30-60 minutes before meals, 3 times daily. The ulcers will be assessed when the drug is applied for 3 days and the level of pain and irritation will be estimated by VAS (Visual Analogue Scale, a scaled ruler which the zero point displays the zone of lack of pain and the 10th point was considered as the zone of maximum pain).

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen, Diphenhydramine and Aluminium MgS3 times daily for 3 days
DRUGDiphenhydramine and Aluminium MgS3 times daily for 3 days

Timeline

Start date
2010-11-01
Primary completion
2011-01-01
Completion
2011-02-01
First posted
2011-02-11
Last updated
2012-06-20
Results posted
2012-06-20

Locations

2 sites across 1 country: Iran

Source: ClinicalTrials.gov record NCT01293968. Inclusion in this directory is not an endorsement.